The Discounted Cash Flow (DCF) valuation of Pacira Biosciences Inc (PCRX) is 4.42 USD. With the latest stock price at 24.90 USD, the upside of Pacira Biosciences Inc based on DCF is -82.2%.
Based on the latest price of 24.90 USD and our DCF valuation, Pacira Biosciences Inc (PCRX) is a sell. selling PCRX stocks now will result in a potential gain of 82.2%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.8% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 0.80 - 22.99 | 4.42 |
| Upside | -96.8% - -7.7% | -82.2% |